GA treatment options in various steps in FDA approval process are discussed by a panel of medical experts. Ryan Haumschild, PharmD, MS, MBA: We’ve given a background of geographic atrophy [GA], but ...

Ryan Haumschild, PharmD, MS, MBA, drives an expert discussion focused on challenges associated with clinical pathway utilization in treating patients with HCC. The panel discussion focused on the ...

In the realm of oncology, the advent of clinical pathways has gained substantial traction in the past two decades as the increasing cost and complexity of cancer care demanded structured, ...

Forbes contributors publish independent expert analyses and insights. Manno writes on education, workforce training, and career pathways. Sep 19, 2024, 02:55pm EDT The jobs-to-be-done theory has ...

The fear of student debt is leading many to choose more affordable alternatives. The fear of student debt is leading many to choose more affordable alternatives to the traditional higher education ...

There is no common journey for a medical device start-up. Most fail, and for those that succeed follow unique paths shaped by market forces, regulatory challenges, and competitive pressures. Bringing ...